Society Pass warned by Nasdaq on $1 bid rule
Society Pass Incorporated has received a notice from Nasdaq that its common stock has closed below the required $1.00 minimum bid price for the last thirty consecutive business days, putting it out of compliance with Nasdaq Listing Rule 5550(a)(2).
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Society Pass Incorporated has received a notice from Nasdaq that its common stock has closed below the required $1.00 minimum bid price for the last thirty consecutive business days, putting it out of compliance with Nasdaq Listing Rule 5550(a)(2).
The company has 180 calendar days, until September 22, 2026, to regain compliance by having its stock close at or above $1.00 for at least ten consecutive business days. The notice does not immediately affect the stock’s listing, but failure to recover by the deadline could lead to delisting, subject to possible extension and appeal.
Positive
- None.
Negative
- Nasdaq bid-price deficiency and delisting risk: SOPA’s shares have traded below Nasdaq’s $1.00 minimum for thirty consecutive business days, starting a 180‑day cure period to regain compliance, with the possibility of further review, corporate actions, and potential delisting if the issue is not resolved.
Insights
Nasdaq bid-price deficiency creates clear delisting risk window for SOPA.
Society Pass has fallen below Nasdaq’s $1.00 minimum bid for thirty straight business days, triggering a formal deficiency notice. The company now operates under a defined 180‑day cure period ending September 22, 2026, during which its stock must close at or above $1.00 for ten consecutive sessions.
The notice alone does not change trading status, but it signals elevated listing risk. If the price does not recover, the company may seek a second 180‑day period, which requires meeting other initial listing standards and formally outlining a cure plan, such as a reverse stock split.
If Nasdaq staff concludes the deficiency cannot be cured or eligibility criteria are not met, the shares could be delisted, though the company would have the right to appeal. Future disclosures will clarify whether the board pursues corporate actions like a reverse split and whether Nasdaq grants any additional grace period.
8-K Event Classification
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What Nasdaq notice did Society Pass (SOPA) receive on March 26, 2026?
How long does Society Pass (SOPA) have to regain Nasdaq bid-price compliance?
Does the Nasdaq deficiency letter immediately affect trading of SOPA stock?
What options might Society Pass (SOPA) consider to regain Nasdaq compliance?
Can Society Pass (SOPA) obtain an additional 180-day Nasdaq compliance period?
AI-generated analysis. How Rhea-AI works. Not financial advice.